Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.

The Lancet. Oncology - 1 Jul 2007

Krämer Alwin, Reiter Andreas, Kruth Jens, Erben Philipp, Hochhaus Andreas, Müller Martin, Cross Nicholas C P, Jones Amy V, Ho Anthony D, Hensel Manfred

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Chronic Disease
Share to Genes, abl
Share to Imatinib Mesylate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Janus Kinase 2

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Piperazines

Share to Pyrimidines

Source

Identifiers

PMID: 17613428
DOI: 10.1016/S1470-2045(07)70206-1

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.PMID 17613428Read ↗

JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.Semantic proximity Read ↗

JAK2 V617F: a single mutation in the myeloproliferative group of disorders.Semantic proximity Read ↗

Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: clinical implications.Semantic proximity Read ↗

Clinical and laboratory relevance of JAK2 V617F and BCR-ABL co-existence in Philadelphia positive CML patients.Semantic proximity Read ↗

JAK2 kinase inhibitors and myeloproliferative disordersSemantic proximity Read ↗

Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms.Semantic proximity Read ↗

Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.Semantic proximity Read ↗

JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders.Semantic proximity Read ↗

The JAK2 V617F mutation in de novo acute myelogenous leukemiasSemantic proximity Read ↗

[JAK2 mutation in myeloproliferative disorders].Semantic proximity Read ↗

Insights into JAK2-V617F mutation in CMLSemantic proximity Read ↗

[JAK2 gene mutation in chronic myeloproliferative disorders].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.